20050-82-2

Basic information

• Product Name: 1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12
• CAS NO: 20050-82-2
• Molecular Formula: C₇H₅N₃OS
• Molecular Weight: 272.688
• Mol File: 20050-82-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12(CAS DataBase Reference)
• NIST Chemistry Reference: 1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12(20050-82-2)
• EPA Substance Registry System: 1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12(20050-82-2)

Safety Data

• Hazardous Substances Data: 20050-82-2(Hazardous Substances Data)

Usage

Chemical structure notation

1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12
This notation provides a detailed representation of the compound's structure, including the positions of the atoms and the hydrogen atoms' arrangement.

Hydrogen atoms

1-4H, (H,10,12
The compound has hydrogen atoms at positions 1-4, with additional hydrogen atoms at positions 10 and 12, as indicated by the notation.

Upstream product

• 93-35-6 7-hydroxy-2H-chromen-2-one 
• 106-47-8 4-chloro-aniline 
• 127-09-3 sodium acetate 
• 67-64-1 acetone 
• 20050-81-1 3-(4-chlorophenyl)-7-acetoxychromen-2-one 
• 1878-66-6 4-chlorophenylacetic Acid 
• 95-01-2 2,4-Dihydroxybenzaldehyde 
• 129742-35-4 4-[(tert-butyldimethylsilyl)oxy]-2-hydroxybenzaldehyde 
• 25307-03-3 4-chlorophenylacetic acid sodium salt 

Downstream Products

• 903584-25-8 7-(2-bromoethoxy)-3-(4-chlorophenyl)-2H-chromen-2-one 
• 717893-45-3 3-(4-chlorophenyl)-7-(2-oxo-2-phenylethoxy)chromen-2-one 
• 887860-30-2 3-(4-chlorophenyl)-7-(2-oxopropoxy)chromen-2-one 
• 887860-85-7 3-(4-chlorophenyl)-7-[2-(3-methoxyphenyl)-2-oxoethoxy]chromen-2-one 

Relevant articles and documents

Combatting AMR: A molecular approach to the discovery of potent and non-toxic rhenium complexes active against C. albicans-MRSA co-infection

Antimicrobial resistance (AMR) is a major emerging threat to public health, causing serious issues in the successful prevention and treatment of persistent diseases. While the problem escalates, lack of financial incentive has lead major pharmaceutical co

Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds

A novel series of coumarin-lipoic acid conjugates were synthesized via cycloaddition click reaction to find out new multi-target-directed ligands (MTDLs) for treatment of Alzheimer's disease (AD). All of synthesized compounds were screened for neuroprotec

Modified coumarins. 29. Synthesis of structural analogs of natural 6-arylfuro[3,2-g]chromen-7-ones

3-Substituted 6-arylfuro[3,2-g]chromen-7-ones, structural analogs of natural furocoumarins, were synthesized by linear annelation of a furan fragment to a 3-arylcoumarin system.